Literature DB >> 26858376

Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.

Annie Haakenstad1, Maxwell Birger2, Lavanya Singh3, Patrick Liu4, Stephen Lim5, Marie Ng6, Joseph L Dieleman7.   

Abstract

In the 2012 Global Vaccine Action Plan, development assistance partners committed to providing sustainable financing for vaccines and expanding vaccination coverage to all children in low- and middle-income countries by 2020. To assess progress toward these goals, the Institute for Health Metrics and Evaluation produced estimates of development assistance for vaccinations. These estimates reveal major increases in the assistance provided since 2000. In 2014, $3.6 billion in development assistance for vaccinations was provided for low- and middle-income countries, up from $822 million in 2000. The funding increase was driven predominantly by the establishment of Gavi, the Vaccine Alliance, supported by the Bill & Melinda Gates Foundation and the governments of the United States and United Kingdom. Despite stagnation in total development assistance for health from donors from 2010 onward, development assistance for vaccination has continued to grow. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Development assistance for health; Health Aid; Vaccines

Mesh:

Substances:

Year:  2016        PMID: 26858376     DOI: 10.1377/hlthaff.2015.1080

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  9 in total

1.  The Causes of Death and Their Influence in Life Expectancy of Children Aged 5-14 Years in Low- and Middle-Income Countries From 1990 to 2019.

Authors:  Juanjuan Liang; Yuanze Du; Xiang Qu; Changrong Ke; Guipeng Yi; Mi Liu; Juncheng Lyu; Yanfeng Ren; Jie Xing; Chunping Wang; Shiwei Liu
Journal:  Front Pediatr       Date:  2022-05-20       Impact factor: 3.569

2.  Funding gap for immunization across 94 low- and middle-income countries.

Authors:  Sachiko Ozawa; Simrun Grewal; Allison Portnoy; Anushua Sinha; Richard Arilotta; Meghan L Stack; Logan Brenzel
Journal:  Vaccine       Date:  2016-10-28       Impact factor: 3.641

3.  Health financing at district level in Malawi: an analysis of the distribution of funds at two points in time.

Authors:  Josephine Borghi; Spy Munthali; Lameck B Million; Melisa Martinez-Alvarez
Journal:  Health Policy Plan       Date:  2018-01-01       Impact factor: 3.344

4.  Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study.

Authors:  Jonathan F Mosser; William Gagne-Maynard; Puja C Rao; Aaron Osgood-Zimmerman; Nancy Fullman; Nicholas Graetz; Roy Burstein; Rachel L Updike; Patrick Y Liu; Sarah E Ray; Lucas Earl; Aniruddha Deshpande; Daniel C Casey; Laura Dwyer-Lindgren; Elizabeth A Cromwell; David M Pigott; Freya M Shearer; Heidi Jane Larson; Daniel J Weiss; Samir Bhatt; Peter W Gething; Christopher J L Murray; Stephen S Lim; Robert C Reiner; Simon I Hay
Journal:  Lancet       Date:  2019-04-05       Impact factor: 79.321

Review 5.  SMART Vaccines 2.0 decision-support platform: a tool to facilitate and promote priority setting for sustainable vaccination in resource-limited settings.

Authors:  Benjamin J J McCormick; Peter Waiswa; Celia Nalwadda; Nelson K Sewankambo; Stacey L Knobler
Journal:  BMJ Glob Health       Date:  2020-11

6.  Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

7.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

Review 8.  Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research.

Authors:  Stephen Resch; Robert Hecht
Journal:  J Glob Health       Date:  2018-06       Impact factor: 4.413

9.  Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework.

Authors:  Natalie Carvalho; Mark Jit; Sarah Cox; Joanne Yoong; Raymond C W Hutubessy
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.